Indicated for the treatment of subclinical mastitis caused by susceptible strains of Staphlycoccus aureus and Streptococcus agalactiae in dry cows
- Provides synergisic antibiotic combination of penicillin and novobiocin
- Batericidal activity against major Staphlococcus and Streptococcus mastitis pahogens
- Ideal duration of activity during the involution phase of the dry cow period, when the keatin plug has not formed and the cow is susceptible to infections
- Contents of one syringe are infused into each quarter at dry off
- 72-hour milk withhold following calving
- 30-day pre-slaughter withdrawl required following administration